Cost and operational context of HPV vaccine delivery in six countries

PATH and immunization program managers in Ethiopia, Guyana, Rwanda, Senegal, Sri Lanka, and Uganda conducted a study to understand the contextual and operational factors to deliver a two-dose human papillomavirus (HPV) vaccination schedule and to estimate their ongoing delivery costs, from the perspective of the health system. These six fact sheets provide focused, high-level study results from each country, including key operational findings and the financial and economic costs per dose for the countries’ HPV vaccination programs.